[1]
Haman, I.O., Vasylechko, M.M., Kocherzhat, O.I. and Vatseba, B.R. 2026. EFFICACY OF DAPAGLIFLOZIN IN THE TREATMENT OF PATIENTS WITH SIGNS OF CARDIO-RENAL-METABOLIC SYNDROME. Clinical and Preventive Medicine. 6 (Sep. 2026), 37-42. DOI:https://doi.org/10.31612/2616-4868.6.2026.05.